+49 152 22 82 97 73
  • Health care

    German Market Access

    Implementation for pharmaceuticals (AMNOG: German Law for Reforming the Market for Pharmaceuticals) and medical devices.

    Read more »

  • Market Access

    Clinical development

    From a payer’s perspective in the various lifecycle stages of a product.

    Read more »

  • Pricing Strategy

    Strategic Payer Plan

    Key questions being answered in a Strategic Payer Plan.

    Read more »

Latest News

Big welcome to our new MArS team member Sebastian Krenberger!!! Sebastian joins us as health economist with a...

Read more

MArS has worked with various companies, patients, patient representatives and payers on various rare disease...

Read more

Why work with us?

Experience

Experience

  • Market access & pricing as well as global clinical development strategies from a payer’s perspective in the various lifecycle stages of a product
  • German market access strategies and implementation for pharmaceuticals (AMNOG: German Law for Reforming the Market for Pharmaceuticals) and medical devices
  • Austrian and Swiss market access strategies and implementation

Knowledge

Knowledge

  • MArS knows what the industry needs and combines the industry, academic and consultancy knowledge of its team members in order to support its customers successfully
  •  

Focused

Focused

MArS focuses on the four topics strategy, Austrian, German and Swiss market access, pricing and health economic strategy & implementation.